Fig. 1: The hyperdynamic interface of MITF represents a vulnerability to pharmacological dimer disruption.

a–d Schematic representations of various aspects of MITF. The three locations (i.e., distinct conformations indicated in colored positions) are adjacent to Ala264 in the leucine zipper (LZ) (a). The 3-residue insertion in the LZ (b). TT-012-mediated disruption of MITF dimerization (c). TT-012 administration in vivo suppresses tumor growth and metastasis of B16F10, a MITFhi melanoma cell line (d). Figure is created with BioRender.